Frontiers in Molecular Biosciences

source: shutterstock.com

Preclinical Study Data on TTX-MC138 for Glioblastoma Accepted for Publication

Post author:Jessica Lynn
Post published:June 21, 2023
Post category:Glioblastoma

TransCode Therapeutics, Inc. (“TransCode”) was founded with a mission to revolutionize the cancer treatment landscape and improve patient outcomes. The company is currently working to uphold this mission through the…

We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.

Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Let’s Work Together!

Keep Up to Date

Learn More